Seasonal Influenza Market to Expand at a Significant Growth Rate During the Forecast Period (2023-32) - Estimates DelveInsight | AlloVir, Cocrystal, Ridgeback Biotherapeutics, Viriom, NanoViricides, Evrys Bio, ETHRIS, Kino Pharma, Emergo Therapeutics

As per DelveInsight, the Seasonal Influenza Market is anticipated to evolve immensely in the coming years owing to the rise in the number of cases of Seasonal Influenza and the launch of new therapies in the market.

Globally, several major pharma and biotech companies are actively working in the Seasonal Influenza Therapeutics market. The entry of mid and late-phase potential molecules like mRNA-1010 (ModernaTX, Inc.), Quadrivalent VLP vaccine (Medicago), NanoFlu (Novavax), SAB-176 (SAb Biotherapeutics) and some others, covering a broad spectrum of seasonal influenza and hold the potential to bring revolution in the prevention and treatment by 2032.

DelveInsight's "Seasonal Influenza Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Seasonal Influenza Market Size and Share in the seven major markets (7MM) (i.e., the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom and Japan).

The market report covers emerging drugs, treatment practices, market share of individual Seasonal Influenza therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current Seasonal Influenza treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of opportunities and assess the underlying potential of the market.

Seasonal Influenza: An Overview
According to World Health Organization (WHO) seasonal influenza is an acute respiratory infection caused by influenza viruses that circulate in all parts of the world. Most people recover from fever and other symptoms within a week without requiring medical attention. However, influenza can cause severe illness or death, particularly among high-risk groups including the very young, the elderly, pregnant women, health workers, and those with serious medical conditions.

According to CDC, there are four types of seasonal influenza viruses, types A, B, C, and D. Influenza A and B viruses circulate and cause seasonal epidemics of disease. Influenza A viruses are the only viruses known to cause flu pandemics, i.e., global epidemics of flu disease. A pandemic can occur when a new and different influenza A virus infects people and can spread efficiently among people. Influenza C virus infections generally cause mild illness and are not thought to cause human epidemics. Influenza D viruses primarily affect cattle and are not known to infect or cause illness in people.

Seasonal Influenza Market Key Facts
• The therapeutic market size of Seasonal Influenza in the 7MM was USD 6,646 million in 2021.
• Among all seven major markets, the US consistently captured the highest market with USD 3,999 million in 2021, which might grow by 2032.
• Among the EU5 countries, Germany holds a total market share of USD 523 million followed by France, Italy, the UK, and Spain in 2021.
• Among 7MM, Japan represented approximately 12% of the total market of seasonal flu in 2021, which is expected to increase by 2032.
• In the EU-5, in 2021, Italy had the highest medical visits related to seasonal influenza with 2,937,446 cases, followed by France with 1,977,533 cases in the same year. On the other hand, Spain had the lowest number of medical visits to seasonal influenza with 228,686 cases in 2021.
• During the peak year of the COVID-19 pandemic, a steep decline in the cases of seasonal influenza was recorded throughout the 7MM. These cases are anticipated to rise again during the forecasted period (2022-2032).

Discover How Seasonal Influenza Market Will Grow by 2032:
https://www.delveinsight.com/report-store/seasonal-influenza-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Seasonal Influenza Market
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted market size by analyzing the impact of current and emerging Seasonal Influenza therapies in the market. It also provides a detailed assessment of the Seasonal Influenza market drivers & barriers, unmet needs, and emerging technologies.

The report gives complete detail of the market trend for each marketed Seasonal Influenza drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MOA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Seasonal Influenza Epidemiology
The epidemiology section covers detailed insights into the historical, and current Seasonal Influenza patient pool and forecasted epidemiology trends for every seven major countries (7MM) from 2019 to 2032.

The Report Covers the Seasonal Influenza Epidemiology Segmented as -
• Total Cases of Seasonal Influenza in the 7MM (2019-2032)
• Type-specific Incident Cases of Seasonal Influenza in the 7MM (Type A and B) (2019-2032)
• Total Vaccinated Cases of Seasonal Influenza in the 7MM (2019-2032)
• Strain-specific Cases Seasonal Influenza in the 7MM (2019-2032)
• Treated Cases of Seasonal Influenza in the 7MM (2019-2032)

Get Key Insights Into the Evolving Seasonal Influenza Epidemiology Trends @
https://www.delveinsight.com/report-store/seasonal-influenza-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Seasonal Influenza Drugs Uptake and Pipeline Development Activities
The drugs' uptake section focuses on the rate of uptake of the potential drugs recently launched in the Seasonal Influenza market or expected to be launched during the study period. The analysis covers the market share by Seasonal Influenza drugs, patient uptake by therapies, and sales of each drug.

The report's drugs uptake section helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs. It allows the comparison of the drugs based on market share and size, which again will be helpful in investigating factors important in understanding the market dynamics and in making financial and regulatory decisions.

The report also covers the Seasonal Influenza Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Explore More About Ongoing Pipeline Development Activities @
https://www.delveinsight.com/sample-request/seasonal-influenza-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Leading Companies in the Seasonal Influenza Therapeutics Market Include
• SAb Biotherapeutics, Inc.
• Emergo Therapeutics, Inc.
• AlloVir
• Cocrystal Pharma
• Poolbeg Pharma
• Ridgeback Biotherapeutics
• Viriom, Inc.
• NanoViricides
• Evrys Bio
• ETHRIS
• Kino Pharma
And Many Others

Emerging and Marketed Seasonal Influenza Therapies Covered in the Report Include
• XOFLUZA (baloxavir marboxil): Genentech/Roche
• FLUZONE QUADRIVALENT /VAXIGRIP TETRA: Sanofi
• SAB-176: SAb Biotherapeutics, Inc.
• mRNA-1010: ModernaTX, Inc.
And Many More

Learn More About the Emerging Therapies & Key Companies in the Seasonal Influenza Therapeutics Market:
https://www.delveinsight.com/sample-request/seasonal-influenza-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Seasonal Influenza Competitive Intelligence Analysis
4. Seasonal Influenza Market Overview at a Glance
5. Seasonal Influenza Background and Overview
6. Seasonal Influenza Patient Journey
7. Seasonal Influenza Epidemiology and Patient Population
8. Seasonal Influenza Treatment Algorithm, Current Treatment, and Medical Practices
9. Seasonal Influenza Unmet Needs
10. Key Endpoints of Seasonal Influenza Treatment
11. Seasonal Influenza Marketed Products
12. Seasonal Influenza Emerging Therapies
13. Seasonal Influenza Seven Major Market Analysis
14. Attribute Analysis
15. Seasonal Influenza Market Outlook (7 major markets)
16. Seasonal Influenza Access and Reimbursement Overview
17. KOL Views on the Seasonal Influenza Market.
18. Seasonal Influenza Market Drivers
19. Seasonal Influenza Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The table of contents is not exhaustive; the final content may vary.

Download the Sample PDF to Get Detailed Insights About the Report's Offerings @
https://www.delveinsight.com/sample-request/seasonal-influenza-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Contact Info:
Shruti Thakur
Manager (Marketing & Branding)
Email: info@delveinsight.com

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

-------------------------------------------- xx --------------------------------------------
Other Trending Healthcare Reports by DelveInsight
Non-Muscle Invasive Bladder Cancer Market
https://www.delveinsight.com/report-store/non-muscle-invasive-bladder-cancer-market

Progressive Familial Intrahepatic Cholestasis Market
https://www.delveinsight.com/report-store/progressive-familial-intrahepatic-cholestasis-pfic-market

Acute Pyelonephritis Market
https://www.delveinsight.com/report-store/acute-pyelonephritis-market

BRAF-Mutant Metastatic Melanoma Market
https://www.delveinsight.com/report-store/braf-mutant-metastatic-melanoma-market

Checkpoint Inhibitor Refractory Cancer Market
https://www.delveinsight.com/report-store/checkpoint-inhibitor-refractory-cancer-market

Contrast-Induced Nephropathy Market
https://www.delveinsight.com/report-store/contrast-induced-nephropathy-market

Hidradenitis Suppurativa Market
https://www.delveinsight.com/report-store/hidradenitis-suppurativa-market

Musculoskeletal Pain Market
https://www.delveinsight.com/report-store/musculoskeletal-pain-market

Corneal Endothelial Dystrophy Market
https://www.delveinsight.com/report-store/corneal-endothelial-dystrophy-market

Cutaneous Lupus Erythematosus Market
https://www.delveinsight.com/report-store/cutaneous-lupus-erythematosus-cle-market

FENEBRUTINIB Market
https://www.delveinsight.com/report-store/fenebrutinib-emerging-insight-and-market-forecast

Hemophilia with Inhibitor Market
https://www.delveinsight.com/report-store/hemophilia-with-inhibitor-market

Pneumothorax Treatment Devices Market
https://www.delveinsight.com/report-store/pneumothorax-treatment-devices-market

Adult Spinal Deformity Market
https://www.delveinsight.com/report-store/adult-spinal-deformity-market

Amyloidosis Market
https://www.delveinsight.com/report-store/amyloidosis-market

Biliary Atresia Market
https://www.delveinsight.com/report-store/biliary-atresia-market

Bronchopulmonary Dysplasia Market
https://www.delveinsight.com/report-store/bronchopulmonary-dysplasia-market

Choroideremia Market
https://www.delveinsight.com/report-store/choroideremia-market

Chronic Hand Eczema Market
https://www.delveinsight.com/report-store/chronic-hand-eczema-market

Complex Regional Pain Syndrome Market
https://www.delveinsight.com/report-store/complex-regional-pain-syndrome-crps-market

Dermal Erythema Market
https://www.delveinsight.com/report-store/dermal-erythema-market

Dry AMD Market
https://www.delveinsight.com/report-store/dry-amd-market

Dysthymia Market
https://www.delveinsight.com/report-store/dysthymia-market

H3N2 Infection Market
https://www.delveinsight.com/report-store/h3n2-infection-market

Parkinson's Disease Related Dementia Market
https://www.delveinsight.com/report-store/parkinsons-disease-related-dementia-market

Partial Onset seizures Market
https://www.delveinsight.com/report-store/partial-onset-seizures-market

Sinus Dilation Devices Market
https://www.delveinsight.com/report-store/sinus-dilation-devices-market

Spinal Cord Stimulators (SCS) Market
https://www.delveinsight.com/report-store/spinal-cord-stimulator-market

Uterine Serous Carcinoma Market
https://www.delveinsight.com/report-store/uterine-serous-carcinoma-market

Contact Info:
Shruti Thakur
Manager (Marketing & Branding)
Email: info@delveinsight.com

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.